New Fluorescent Calix Crown Ethers
3
7.22–7.27 (m, 5 H, ArH), 6.84 (d, J = 8.8 Hz, 1 H, ArH), 6.09 (s,
6 (72 mg, 0.14 mmol) in ethanol (40 mL), Pd/C (10%, 68 mg) was
1 H, C=CH), 4.08–4.16 (m, 8 H, OCH2CH2O), 3.70–3.81 (m, 8 H, added. Hydrogen was discharged into the solution for 25 min, and
OCH2CH2O), 2.37 (s, 6 H, CH3), 2.34 (s, 3 H, CH3) ppm. 13C
the solution was heated to 60 °C for 2 h. The reaction was moni-
NMR (CDCl3, 125 MHz, 27 °C): δ = 160.5, 154.5, 152.6, tored by MALDI-ToF. After complete conversion, the catalyst was
144.8,144.7, 135.6, 132.8, 129.8, 127.9, 119.6, 112.4, 109.8, 72.9,
70.6, 69.6, 69.5, 69.3, 68.9, 68.8, 68.6, 43.0, 21.6, 18.7 ppm. HRMS
filtered off, and the solvent was removed in vacuo. The crude prod-
uct was filtered through basic alumina (CHCl3/MeOH, 1:1) and
(ESI): m/z calcd. for C32H36O12S2 [M + H]+ 677.17209; found purified by flash column chromatography (Al2O3, CHCl3/MeOH,
677.17162. IR (ATR): ν = 3090, 3064, 2946, 2924, 2873, 2363, 2328,
98:2) to give a colourless solid (25 mg, 0.07 mmol, 50%). 1H NMR
˜
1723, 1601, 1563, 1507, 1448, 1384, 1352, 1296, 1244, 1174, 1136,
(CDCl3, 500 MHz, 27 °C): δ = 7.24 (d, 3J = 8.8 Hz, 1 H, ArH),
1094, 1038, 1016, 964, 919, 815, 772, 705, 690, 663, 582, 554 cm–1.
6.84 (d, J = 8.8 Hz, 1 H, ArH), 6.11 (s, 1 H, C=CH), 4.33 (t, J
= 3.8 Hz, 2 H, OCH2CH2O), 4.17 (t, 3J = 3.8 Hz, 2 H, OCH2-
CH2O), 3.88 (t, 3J = 4.1 Hz, 2 H, OCH2CH2O), 3.78 (t, 3J =
4.1 Hz, 2 H, OCH2CH2O), 3.73 (t, 3J = 4.7 Hz, 2 H, OCH2CH2O),
3.67 (t, 3J = 4.7 Hz, 2 H, OCH2CH2O), 2.88–2.80 (m, 4 H, NCH2),
2.36 (s, 3 H, CH3) ppm. 13C NMR (CDCl3, 125 MHz, 27 °C): δ =
160.7, 154.7, 152.8, 148.0, 135.0, 119.4, 114.7, 112.2, 108.3, 73.2,
69.8, 69.6, 68.5, 68.2, 68.1, 48.3, 47.8, 18.8 ppm. HRMS (ESI): m/z
calcd. for C18H24NO6 [M + H]+ 350.15981; found 350.15959. IR
3
3
7-Benzyl-16-methyl-2,3,5,6,8,9,11,12-octahydrochromeno[7,8-b]-
[1,4,10,13,7]tetraoxaazacyclopentadecin-18-one (5): In a solution of
chromenone 4 (1.02 g, 150 mmol) and benzylamine (0.16 g,
150 mmol) in toluene (150 mL), Na2CO3 (1.59 g, 14.99 mmol) was
suspended. The mixture was refluxed under argon for 6 d. The re-
action mixture was cooled to room temperature, and the solid was
filtered off. Methanol (4 mL) was added to the filtrate, and the
mixture was stirred at 50 °C for 40 min. The solvent was evaporated
in vacuo, and the crude product was purified by column
chromatography (Al2O3, ethyl acetate/cyclohexane, 45:55) to give a
colourless solid (0.31 g, 0.7 mmol, 47%). The crown ether can be
recrystallised from ethanol. 1H NMR (CDCl3, 500 MHz, 27 °C): δ
(ATR): ν = 3317, 2926, 2871, 1728, 1604, 1508, 1449, 1385, 1298,
˜
1098 cm–1.
Cavitand 9: A mixture of aza-crown ether 7 (18 mg, 0.05 mmol),
cavitand 8[10] (76 mg, 0.06 mmol) and Cs2CO3 (43 mg, 0.13 mmol)
in dry N,N-dimethylformamide (6 mL) was stirred under argon at
80 °C for 2 h. The solvent was removed in vacuo, and the precipi-
tate was dissolved in chloroform and washed with water. The aque-
ous phase was extracted twice with chloroform, and the combined
organic phases were concentrated. The crude product was purified
by flash column chromatography (Al2O3, CHCl3/MeOH, 99:1) to
give the calix crown ether as a colourless solid (45 mg, 0.03 mmol,
60%). 1H NMR (CDCl3, 500 MHz, 27 °C): δ = 7.26 (d, 3J =
8.8 Hz, 1 H, ArH, coumarin), 7.09 (s, 3 H, ArH), 7.04 (s, 1 H,
ArH), 6.83 (d, 3J = 8.8 Hz, 1 H, ArH, coumarin), 6.46 (s, 1 H,
3
= 7.17–7.25 (m, 6 H, ArH), 6.83 (d, J = 8.8 Hz, 1 H, ArH), 6.10
(s, 1 H, C=CH), 4.28 (m, 2 H, OCH2CH2O), 4.18 (m, 2 H, OCH2-
CH2O), 3.91 (m, 2 H, OCH2CH2O), 3.83 (m, 2 H, OCH2CH2O),
3.72 (m, 2 H, OCH2CH2O), 3.69 (m, 2 H, OCH2CH2O), 3.66 (s, 2
H, PhCH2), 2.80–2.83 (m, 4 H, NCH2), 2.35 (s, 3 H, CH3) ppm.
13C NMR (CDCl3, 125 MHz, 27 °C): δ = 160.6, 155.0, 152.6, 148.0,
139.3, 135.2, 128.8, 128.1, 126.8, 119.5, 114.7, 112.2, 108.6, 73.1,
70.4, 70.1, 69.4, 69.0, 68.9, 60.6, 54.1, 53.9, 29.2, 18.7 ppm. HRMS
(ESI): m/z calcd. for C25H29NO6 [M + H]+ 440.20676; found
440.20660. IR (ATR): ν = 3084, 3061, 3026, 2961, 2867, 2247, 1725,
˜
3
ArH), 6.43 (s, 2 H, ArH), 6.12 (s, 1 H, CH, coumarin), 5.80 (d, J
1646, 1604, 1562, 1507, 1495, 1448, 1439, 1384, 1367, 1360, 1297,
1241, 1203, 1177, 1129, 1096, 1045, 1028, 962, 911, 871, 849, 801,
772, 730, 699, 664, 646, 554 cm–1.
3
= 7.5 Hz, 2 H, OCH2O), 5.72 (d, J = 7.5 Hz, 2 H, OCH2O), 4.70
(t, 3J = 8.2 Hz, 4 H, ArCHAr), 4.43 (d, 3J = 6.9 Hz, 2 H, OCH2O),
4.30 (d, 3J = 6.9 Hz, 2 H, OCH2O), 4.29 (t, 3J = 4.6 Hz, 2 H,
3
3
7-(Diphenylmethyl)-16-methyl-2,3,5,6,8,9,11,12-octahydrochromeno-
[7,8-b][1,4,10,13,7]tetraoxaazacyclopentadecin-18-one (6): To a solu-
tion of chromenone 4 (1.02 g, 1.51 mmol) and aminodiphenylme-
thane (0.3 g, 1.64 mmol) in toluene (150 mL), Na2CO3 (1.6 g,
151 mmol) was added. The mixture was refluxed for 8 d, and ad-
ditional aminodiphenylmethane (0.16 g, 0.87 mmol) was added.
The mixture was refluxed for 2 d, and the solid was filtered of.
The filtrate was concentrated in vacuo, and the crude product was
purified by flash column chromatography (SiO2, ethyl acetate/
cyclohexane 7:3) to give a colourless solid (667 mg, 1.29 mmol,
86 %). The crown ether can be recrystallised from ethanol. 1H
NMR (CDCl3, 500 MHz, 27 °C): δ = 7.11–7.43 (m, 11 H, ArH),
OCH2CH2O), 4.17 (t, J = 3.8 Hz, 2 H, OCH2CH2O), 3.89 (t, J
= 3.5 Hz, 2 H, OCH2CH2O), 3.82 (t, 3J = 4.1 Hz, 2 H, OCH2-
CH2O), 3.73 (t, J = 5.4, 4 H, OCH2CH2O), 3.47 (s, 2 H, ArCH2),
3
2.84–2.74 (m, 4 H, NCH2CH2), 2.36 (s, 3 H, CH3, coumarin), 2.28–
2.08 (m, 8 H, CHCH2), 1.48–1.16 (m, 72 H, CH2), 0.86 (t, 3J =
6.9 Hz, 12 H, CH3) ppm. 13C NMR (CDCl3, 125 MHz, 27 °C): δ
= 160.6, 155.0, 1554.8, 154.7, 154.3, 152.6, 148.0, 138.4, 138.3,
138.1, 138.0, 135.2, 123.7, 120.6, 120.5, 119.7, 119.6, 116.5, 116.3,
114.8, 112.3, 108.6, 99.6, 99.5, 73.1, 70.2, 69.8, 69.0, 68.8, 53.0,
52.9, 48.6, 36.6, 36.3, 31.9, 30.1, 29.9, 29.8, 29.7, 29.4, 27.9, 27.87,
22.7, 18.8, 14.1 ppm. HRMS (ESI): m/z calcd. for C95H135NO14 [M
+ H]+ 1514.99553; found 1514.99984. IR (ATR): ν = 2920, 2851,
˜
3
1724, 1605, 1491, 1456, 1296, 1094, 1020, 965 cm–1.
6.84 (d, J = 8.8 Hz, 1 H, ArH), 6.12 (s, 1 H, C=CH), 4.80 (s, 1 H,
3
3
Bnz), 4.29 (dd, J = 4.4 Hz, J = 4.4 Hz, 2 H, OCH2CH2O), 4.17
Crystal Structure Determination: CCDC-681208, -681209, -681210
and -681211 contain the supplementary crystallographic data for
this paper. These data can be obtained free of charge from The
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/
data_request/cif. Crystal Data for 5: C25H29NO6, M = 439.49, tri-
clinic, a = 8.6458(2), b = 9.2239(2), c = 14.9930(3) Å, α =
(dd, 3J = 3.8 Hz, 3J = 3.8 Hz, 2 H, OCH2CH2O), 3.86 (dd, 3J =
3
3
3
4.4 Hz, J = 4.4 Hz, 2 H, OCH2CH2O), 3.78 (dd, J = 3.8 Hz, J
= 3.8 Hz, 2 H, OCH2CH2O), 3.74 (t, 3J = 5.6 Hz, 2 H, OCH2-
CH2O), 3.64 (t, 3J = 6.1 Hz, 2 H, OCH2CH2O), 2.80–2.90 (m, 4
H, NCH2), 2.36 (s, 3 H, CH3) ppm. 13C NMR (CDCl3, 125 MHz,
27 °C): δ = 160.7, 155.0, 152.7, 148.0, 142.6, 135.2, 128.4, 128.3,
126.9, 119.5, 114.8, 112.3, 108.7, 73.1, 71.3, 70.2, 70.0, 69.3, 69.0,
52.2, 52.0, 18.7 ppm. HRMS (ESI): m/z calcd. for C31H33NO6 [M
85.0614(11), β = 79.7561(12), γ = 73.8471(12)°, V = 1129.31(4) Å3,
–1
¯
T = 200 K, space group P1, Z = 2, µ(Mo-Kα) = 0.092 mm , 28810
reflections measured, 5152 unique (Rint = 0.030), which were used
in all calculations. The final R values were R(F) = 0.0439 for 4181
reflections with I Ͼ 2σI and wR(F2) = 0.1250 for all data. Crystal
Data for the NaI Complex of 5: C29H41INNaO8, M = 681.52, tri-
clinic, a = 10.2040(9), b = 11.2107(4), c = 15.6238(9) Å, α =
69.016(4), β = 81.114(6), γ = 67.451(5)°, V = 1540.86(17) Å3, T =
+ H]+ 516.23806; found 516.23808. IR (ATR): ν = 3024, 2925,
˜
2865, 1724, 1602, 1562, 1502, 1448, 1383, 1295, 1240, 1126, 1093,
1024, 907, 850, 727, 705 cm–1.
16-Methyl-2,3,5,6,8,9,11,12-octahydrochromeno[7,8-b][1,4,10,13,7]-
tetraoxaazacyclopentadecin-18-one (7): Tο a solution of crown ether
Eur. J. Org. Chem. 2008, 5231–5238
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5237